Cystic Fibrosis Market Growth Drivers Include Sustainability Push and Digital Transformation
Market Overview According to the research report, the Cystic fibrosis market was valued at USD 5.75 billion in 2021 and is expected to reach USD 37.04 billion by 2030, to grow at a CAGR of 24.3% during the forecast period. Cystic fibrosis is one of the most common chronic lung diseases among children and young adults. It is caused by mutations in the CFTR gene, which leads to the production of thick, sticky mucus that clogs airways and obstructs the pancreas. The global market for cystic fibrosis encompasses a wide range of products, including prescription drugs, enzyme supplements, nutritional therapies, and respiratory support devices. With increasing diagnosis rates and a growing patient pool, the demand for innovative treatment options has surged in recent years. The market is characterized by the presence of several pharmaceutical and biotechnology firms working toward the development of novel therapies. These companies are focusing on expanding their product por...